CLINICAL_TRIALS
trial_result
· 2024-08-12
Clinical Trial Update: Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Summary
Phase 1 study of MEN1112 intravenous infusion in relapsed or refractory acute myeloid leukemia was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Menarini Group | Conditions: Recurrent Adult Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse | Phase 1 | Status: TERMINATED | Results posted: 2024-08-12